- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04969042
Closed-loop Functional Spinal Cord Stimulation in Patients With Spinal Cord Injury (COFUN)
July 11, 2021 updated by: Luming Li
Efficacy of Closed-loop Functional Spinal Cord Stimulation on Walking Rehabilitation in Patients With Spinal Cord Injury
The purpose of this experiment is to evaluate the efficacy of Closed-loop Functional Spinal Cord Stimulation on Walking Rehabilitation in Patients after Spinal Cord Injury
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The whole course will last around 12 months, during which there will be: Pre-implant evaluations and standard rehabilitation (6-10 weeks), Stimulator implantation and stimulation optimization (4-8 weeks), Rehabilitation training with stimulation (6 months).
At the end of the protocol, the study aims to make the patients walk better and faster.
Study Type
Interventional
Enrollment (Anticipated)
10
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Yang Lu, MD
- Phone Number: +8656119530
- Email: yanglu@btch.edu.cn
Study Locations
-
-
Beijing
-
Beijing, Beijing, China
- Recruiting
- National Engineering Laboratory for Neuromodulation
-
Contact:
- Yang Lu, MD
- Email: yanglu@btch.edu.cn
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 18~70
- Spinal cord injury staging(AIS) A,B,C or D
- Level of lesion is T10 and above
- Distance between lesion and conus >60mm
- Injured Time > 3 months
- Capable of participating rehabilitation program
- Agree to comply with all conditions of the study and to attend all required study training and visits
Exclusion Criteria:
- With Obvious psychiatric disorder that cannot complete relevant questionaires
- Cognitive impairment
- Severe autonomic reflex disorder
- Severe muscle atrophy and joint contracture
- Cannot participate in spinal cord stimulation surgery or follow-up visits
- Life expectancy less than 12 months
- Abnormal blood or other physiological examinations that cannot conduct surgery, such as blood coagulation disorder or kidney/liver abnormalities
- Uncontrollable hypertension, heart diseases, respiratory diseases or took related medicine in last 3 months
- Unsuitable candidates in PI's perspective
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Stimulation
Participants will receive pre-implantation rehabilitation, implantation of the closed-loop spinal cord stimulator, and stimulation (according to the functional mapping) assisted rehabilitation post-implantation during the trial.
|
G122RS model implanted spinal cord stimulation device, which could give closed-loop functional stimulation in the epidural space
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
WISCI III
Time Frame: Change from Baseline to the 8 month after implantation.
|
A Common method used to evaluate SCI patient's walking capability in clinical setting
|
Change from Baseline to the 8 month after implantation.
|
10-metre Walking Test 10-metre Walking Test 10-metre Walking Test 10 meter wlaking
Time Frame: Change from Baseline to the 8 month after implantation.
|
10-Meter Walk Test (10MWT) is commonly used to measure walking speeds during two conditions: a self-selected normal speed, and a self-selected 'faster-than-normal' speed.
|
Change from Baseline to the 8 month after implantation.
|
Weight Bearing Capacity
Time Frame: Change from Baseline to the 8 month after implantation.
|
Weight-bearing capacity (WBC) is an important outcome to monitor and particularly relevant in patients with severe motor impairments who cannot walk independently.
The investigators use LPG HUBER360 to examine subjects' weight bearing capacity
|
Change from Baseline to the 8 month after implantation.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Luming Li, PhD, National Engineering Laboratory for Neuromodulation
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
August 1, 2021
Primary Completion (Anticipated)
August 1, 2026
Study Completion (Anticipated)
August 1, 2027
Study Registration Dates
First Submitted
July 6, 2021
First Submitted That Met QC Criteria
July 11, 2021
First Posted (Actual)
July 20, 2021
Study Record Updates
Last Update Posted (Actual)
July 20, 2021
Last Update Submitted That Met QC Criteria
July 11, 2021
Last Verified
July 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 202000325
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spinal Cord Injuries
-
Khon Kaen UniversityUnknownInjuries, Spinal Cord
-
Universidade do Vale do ParaíbaCompletedInjuries, Spinal Cord
-
InVivo TherapeuticsTerminated
-
Ekso BionicsBurke Medical Research InstituteCompletedInjuries, Spinal CordUnited States
-
ReWalk Robotics, Inc.Unknown
-
Shepherd Center, Atlanta GACompletedInjuries, Spinal Cord
-
Wroclaw Medical UniversityInstitute of Immunology and Experimental Therapy of the Polish Academy of... and other collaboratorsUnknownComplete Spinal Cord InjuriesPoland
-
Lineage Cell Therapeutics, Inc.CompletedCervical Spinal Cord Injury | Spine Injury | Spinal Cord TraumaUnited States
Clinical Trials on Pins Medical G122 RS
-
Xijing HospitalRecruiting
-
Beijing Pins Medical Co., LtdCompleted
-
VA Office of Research and DevelopmentRecruitingAutologous Hematopoietic Stem Cell TransplantUnited States
-
Michal Roll PhD,MBAUnknownPleural Effusion
-
Beijing Pins Medical Co., LtdUnknownIdiopathic Parkinson PatientsChina
-
Beijing Pins Medical Co., LtdBeijing Tiantan HospitalUnknown
-
Campus Bio-Medico UniversityUnknown
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingGlioma | Brain MassUnited States